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EDITORIAL COMMENT
Congenital Ductus
Arteriosus Aneurysm*
Lisa K. Hornberger, MD
Toronto, Ontario
Congenital ductus arteriosus aneurysm (DAA) is a saccular
or fusiform dilation and elongation of the ductus arteriosus.
By chest X-ray, it is recognized as a ductal bump (1). More
recently, echocardiography has been the primary modality
used to demonstrate the pathology (2,3). Although most
commonly diagnosed within the first two months after birth
(2), the pathology may also be diagnosed prenatally (2–5).
Previously, DAA was considered a rare cardiovascular le-
sion, described predominantly in isolated case reports, and
typically detected in association with significant complica-
tions, including thromboembolism, compression of sur-
rounding thoracic structures and spontaneous rupture (3,6–
10). It has also been observed in patients with connective
tissue disorders (3,6,11–13).
Incidence of congenital DAA. Recent reports, including
the current study by Jan et al. (14) in this issue of the
Journal, suggest DAA may be much more common among
fetuses and neonates than previously suspected. An early
study of neonatal autopsies revealed a 0.8% incidence of
DAA (15). In a retrospective review of neonatal X-rays,
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Heikkinen et al. (16) determined the incidence of a ductal
bump to be 1%. We found that among 200 consecutively
assessed third-trimester fetuses, 1.5% had DAA, but used a
ductus arteriosus diameter of 2 SD above the mean for
gestational age as an arbitrary cutoff (3). In their current,
prospective, echocardiographic investigation of 548 full-
term neonates, Jan et al. (14) have demonstrated an even
higher incidence of congenital DAA, providing evidence
that this may, in fact, represent a variant of normal anatomy.
As observed most frequently among our prenatally diag-
nosed cases (3), the majority of affected neonates in their
study were clinically asymptomatic. As such, without echo-
cardiographic assessment, the DAA would have gone un-
detected.
It is of note that in the current study the measured DAAs
were smaller than many described in our study (3) and in
some of the previously published case reports. The mean
DAA diameter measured in our cohort of patients was
12.6  4.1 mm, with a range of 8 to 24 mm. In fact, nearly
half of the cases from our previous report had DAA
diameter measurements that were 11.2 mm. Given the
unbiased prospective investigation of Jan et al. (14), most
affected neonates may have smaller DAA with the more
symptomatic patient having the larger DAA diameter.
From the data presented, the true incidence of larger DAAs
among newborns remains unclear.
As observed in our retrospective study (3) and in other
isolated case reports (2,5), Jan et al. (14) further demon-
strate the natural history of the smaller DAA to be benign
in the majority of affected neonates, with 70% demonstrat-
ing progressive diminution in size of the DAA following
spontaneous closure. Even in subjects with evidence of
thrombus formation (30%), they found both the DAA and
thrombus to have “resolved” by one month.
Management of the patient with congenital DAA.
Although congenital DAA may be a variant of normal
anatomy given its frequent occurrence, the potential com-
plications of DAA cannot be completely ignored. Several
reports have documented spontaneous rupture of DAA,
often with dismal outcome (3,7,16–18). Patients with
connective tissue disease may be at highest risk of sponta-
neous rupture. Extension of the DAA thrombus into the
pulmonary arteries or aorta and thromboembolic events
have been described in DAA (3,8,9). Also, DAA has been
associated with infection (9). Finally, a larger DAA may
compress surrounding vascular and nonvascular structures,
including airways and the recurrent laryngeal nerve
(3,7,16,17,19). The true incidence of these complications is
not clear. In our retrospective review, we found 3 of 24
patients to have complications related to the DAA. How-
ever, in six patients early surgical resection was performed
for larger DAA to thwart such complications (3). In
contrast, Jan et al. (14) found no complications among 48
neonates with smaller DAA. It is likely that, if the incidence
of DAA is as much as 8% to 9%, then the incidence of
complications associated with DAA may be much less than
we had observed.
When caring for an infant with DAA, the presence or
potential risk of complications must guide one’s decision
regarding need for surgical intervention. Larger DAA may
be more commonly associated with complications. How-
ever, even smaller DAA might be associated with sponta-
neous rupture in the patient with connective tissue disease
(3). Having reviewed the literature and our own experience
(as referenced in the study by Jan et al. (14)), we had
proposed that surgical resection of DAA be considered if: 1)
the ductus arteriosus with DAA remains patent beyond the
neonatal period; 2) the DAA is associated with connective
tissue disease; 3) there is evidence of thrombus extension
into other vessels or thromboembolism; or 4) there is
significant compression of adjacent structures. Given the
observations of Jan et al. (14) these recommendations might
be modified at least for the otherwise healthy, asymptomatic
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neonate in whom it may be prudent to wait at least four to
six weeks before considering surgical resection. When there
are symptoms of compression that are only mild, it may also
be reasonable to wait for such a period of time to see
whether the DAA will spontaneously close, resulting in less
severe compression. It is unclear whether the larger DAA,
however, would undergo spontaneous closure. Furthermore,
waiting in this situation may risk thrombus extension into
the pulmonary artery or aorta, thromboembolic events and
even rupture.
In addition to surgical considerations, close follow-up of
the symptomatic infant or infant with the larger DAA is
important; however, the necessity of follow-up of the
asymptomatic neonate with the smaller DAA and sponta-
neous ductus arteriosus closure requires reconsideration.
Because we had observed late development of cardiac
manifestations of connective tissue disease in two cases of
our series, we had suggested that serial assessment of all
affected patients should be considered (3). Given the high
incidence of DAA in neonates documented by Jan et al.
(14), however, this may not be feasible or practical. In the
infants with smaller DAA and spontaneous ductus arterio-
sus closure, assuming there is no family history or clinical
evidence of connective tissue disease, it may be more
appropriate to mention the possible association with the
primary health care provider. Referral to a cardiologist,
however, should be encouraged should the child develop
other manifestations of connective tissue disease.
Pathogenesis of congenital DAA. Despite the numerous
reports documenting the diagnosis of DAA, the pathogen-
esis of DAA remains unclear; DAA has been uniformally
identified in utero in the third trimester and has not been
observed earlier in gestation, despite widespread use of
obstetrical ultrasound screening in midtrimester pregnan-
cies. This suggests a late onset of prenatal development,
perhaps due to an altered circulation, weakening of the wall
of the ductus arteriosus or a combination of both. It is
during the third trimester that the arterial blood pressure
and cardiac output are greatest (19). It is also in this period
that intimal cushions begin to form within the ductus
arteriosus in preparation for postnatal closure (20,21).
Based on histological assessment of cases in our series, we
suggested that, at least in some cases, DAA may result from
lack of normal intimal cushion formation (3). We hypoth-
esized that an inadequate amount of fibronectin, which is
produced by the vascular smooth muscle cells and is re-
quired for their proliferation (22,23), may inhibit formation
of the cushions. Although intimal cushions may not be
present in DAA, constriction of the ductus arteriosus and
even DAA might still take place after birth, providing an
explanation for observations related to closure of DAA in
the absence of thrombosis. Abnormal elastin deposition has
also been observed in some cases of DAA, which may result
in weakening of the wall of the ductus arteriosus (3). Finally,
abnormal extracellular matrix deposition within the wall of
the ductus arteriosus may occur in the setting of connective
tissue disorders.
Jan et al. (14) had found an increased incidence of
neonatal DAA in infants of diabetic mothers and in large
for their gestational age infants. This could perhaps be due
to the presence of circulating factors that alter the fetal or
placental circulation. Fetal echocardiography studies in
pregnancies complicated by diabetes have shown hyperdy-
namic right ventricular systolic function in the fetus (24)
and altered umbilical arterial flow patterns, suggesting
increased placental vascular resistance in some affected
pregnancies (25,26). Circulating factors may also have a
more direct influence on development of intimal cushions or
extracellular matrix deposition in the ductus arteriosus. For
instance, it has been shown that hyperglycemia in diabetes
enhances vascular endothelial cell production of matrix
metalloproteinases, enzymes responsible for the breakdown
of extracellular matrix components (27,28).
The mechanism by which maternal blood group A, as
shown by Jan et al. (14) to be a more common finding
among neonates with DAA, could influence development of
DAA is less clear. It is not likely a simple process related to
B antibodies, given that infants of mothers with blood
group O are not similarly affected. The link between
maternal blood group and DAA development in the fetus is
likely much more complicated. Differences in blood group
antigen secretion have been shown to drastically alter
carbohydrates present in body fluids, including serum (29),
which could suggest the potential for circulating maternal
factors that might induce fetal DAA development. The
diverse biologic role of blood group antigens (e.g., trans-
porters and channels, receptors, adhesion molecules, en-
zymes and structural proteins) and their potential genetic
links to disease states are only beginning to be recognized
(29,30). At this stage, animal models of abnormal intimal
cushion formation or extracellular matrix formation and
deposition may provide further insight into the factors that
influence DAA development.
Conclusions. In summary, congenital DAA is more com-
mon than previously suspected, as demonstrated by the
work of Jan et al. (14). The incidence of larger DAA, which
may be more frequently associated with complications,
however, remains uncertain. Given the benign course of
small DAA, surgical intervention for DAA should be
reserved when there is patency of the ductus arteriosus
beyond four to six weeks. It may still be appropriate to
consider early intervention for the larger DAA, DAA in
patients with connective tissue disease and in the setting of
significant symptoms or complications associated with the
DAA. Further prospective population-based and multi-
center studies could result in a better sense of the true
incidence of complications associated with this pathology,
particularly with larger DAAs, and may lead to the devel-
opment of more appropriate, evidence-based guidelines in
the management of affected patients.
349JACC Vol. 39, No. 2, 2002 Hornberger
January 16 2002:348–50 Editorial Comment
Reprint requests and correspondence: Dr. Lisa K. Hornberger,
Division of Cardiology, Hospital for Sick Children, 555 University
Avenue, Toronto, Ontario M5R1W7 Canada. E-mail: lisa.
hornberger@sickkids.on.ca.
REFERENCES
1. Berdon WE, Baker DH, James LS. The ductus bump: a transient
physiologic mass in chest roentgenograms of newborn infants. Am J
Roentgenol 1965;95:91–8.
2. Lund JT, Hansen D, Brocks V, Jensen MB, Jabobsen JR. Aneurysm
of the ductus arteriosus in the neonate: three case reports with a review
of the literature. Pediatr Cardiol 1992;13:222–6.
3. Dyamenahalli U, Smallhorn JF, Geva T, et al. Isolated ductus
arteriosus aneurysm in the fetus and infant: a multi-institutional
experience. J Am Coll Cardiol 2000;36:262–9.
4. Puder KS, Sherer DM, Ross RD, et al. Prenatal ultrasonographic
diagnosis of ductus arteriosus aneurysm with spontaneous neonatal
closure. Ultrasound Obstetr Gynecol 1995;5:342–5.
5. Better DJ, Timchak DM, Allan LD. Prenatal diagnosis of aneurysm of
the arterial duct: postnatal management and literature review. Cardiol
Young 1997;7:160–2.
6. Lund JT, Jensen MB, Hjelms E. Aneurysm of the ductus arteriosus: a
review of the literature and the surgical implications. Eur J Cardio-
thorac Surg 1991;5:566–70.
7. Ithuralde M, Halloran KH, Fishbone G, Brill S, Downing SE.
Dissecting aneurysm of the ductus arteriosus in the newborn infant.
Am J Dis Child 1971;122:165–9.
8. Dworsky M, Kohaut E, Jander HP, Ceballos R. Neonatal embolism
due to thrombosis of the ductus arteriosus in the newborn infant.
Radiology 1980;134:573–6.
9. Falcone MW, Perloff JK, Roberts WC. Aneurysm of the nonpatent
ductus arteriosus. Am J Cardiol 1971;29:422–6.
10. Malone PS, Cooper SG, Elliot M, Kiely EM, Spitz L. Aneurysm of
the ductus arteriosus. Arch Dis Child 1989;64:1386–8.
11. Amato JJ, Cardarelli MG, Bierman FZ. Aneurysm of the arterial
duct—a case report and review of the literature. Cardiol Young
1991;4:87–9.
12. Crisfield RJ. Spontaneous aneurysm of the ductus arteriosus in a
patient with Marfan’s syndrome. J Thorac Cardiovasc Surg 1971;62:
243–7.
13. Chang J-P, Chang C-H, Sheih M-J. Aneurysmal dilation of patent
ductus arteriosus in a case of Ehlers-Danlos syndrome. Ann Thorac
Surg 1987;44:656–7.
14. Jan S-L, Hwang B, Fu Y-C, Chai J-W, Chi C-S. Isolated neonatal
ductus arteriosus aneurysm. J Am Coll Cardiol 2002;39:342–7.
15. Thore J. De l’aneurysme du canal arteriel (8 cases). Arch Gen Med
(Paris) 1850;23:30.
16. Heikkinen ES, Simila S, Laitinen J, Larmi T. Infantile aneurysm of
the ductus arteriosus. Acta Pediatr Scand 1974;63:241–8.
17. Ferlic RM, Hofschire PJ, Mooring PK. Ruptured ductus arteriosus
aneurysm in an infant: report of a survivor. Ann Thorac Surg
1975;20:456–60.
18. Birrell JHW. Three aneurysms of the ductus arteriosus. Aust Ann
Med 1954;3:37–43.
19. Adamson SL, Myatt L, Byrne BMP. Regulation of umbilical blood
flow. In: Polin RA, Fox WW, eds. Fetal and Neonatal Physiology.
Philadelphia, PA: W.B. Saunders, 1998:979–81.
20. Silver MM, Freedom RM, Silver MD, Olley PM. The morphology of
the human newborn ductus arteriosus. Hum Pathol 1981;12:1123–36.
21. Gittenburger de Groot AC, Ertbruggen IV, Moulaert AJMG,
Harinck E. The ductus arteriosus in the preterm infant: histologic and
clinical observations. J Pediatr 1980;96:88–93.
22. Rabinovitch M. Cell-extracellular matrix interactions in the ductus
arteriosus and perinatal pulmonary circulation. Semin Perinatol 1996;
20:531–41.
23. Boudreau N, Turley E, Rabinovitch M. Fibronectin, hyaluronan and
a hyaluronan binding protein contribute increased ductus arteriosus
smooth muscle cell migration. Dev Biol 1991;143:235–47.
24. Ghandi JA, Zhang XY, Maidman JE. Fetal cardiac hypertrophy and
cardiac function in diabetic pregnancies. Am J Obstet Gynecol
1995;173:1132–6.
25. Ursem NT, Clark EB, Keller BB, Wladimiroff JW. Fetal heart rate
and umbilical artery velocity variability in pregnancies complicated by
insulin-dependent diabetes mellitus. Ultrasound Obstet Gynecol 1999;
13:312–6.
26. Friedman DM, Ehrlich P, Hospkins IA. Umbilical artery Doppler
blood velocity waveforms in normal and abnormal gestations. J
Ultrasound Med 1989;8:375–80.
27. Uemura S, Matsushita H, Li W, et al. Diabetes mellitus enhances
vascular matrix metalloproteinase activity: role of oxidative stress. Circ
Res 2001;88:1291–8.
28. Pustovrh C, Jawerbaum A, Sinner D, et al. Membrane-type matrix
metalloproteinase-9 activity in placental tissue from patients with
pre-existing and gestational diabetes mellitus. Reprod Fertil Dev
2000;12:269–75.
29. D’Adamo PJ, Kelly GS. Metabolic and immunologic consequences of
ABH secretor and Lewis subtype status. Altern Med Rev 2001;6:390–
405.
30. Carton JP, Colin Y. Structural and functional diversity of blood group
antigens. Transfus Clin Biol 2001;8:163–99.
350 Hornberger JACC Vol. 39, No. 2, 2002
Editorial Comment January 16 2002:348–50
